Compare ImmunityBio Inc. Common Stock (IBRX) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Liberty Global Ltd Class C — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Liberty Global Ltd Class C trades at $8.79 (market cap $3.12B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 3.3× Liberty Global Ltd Class C's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Liberty Global Ltd Class C for 21 Days on average.
| IBRX | LBTYK | |
|---|---|---|
Market Cap | $10.33B | $3.12B |
Volume | 11,745,198 | 1,096,842 |
Sector | Health | Media |
52-Week High | $11.55 | $12.67 |
52-Week Low | $1.98 | $8.75 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $10.79B | $9.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LBTYK is trading at $8.92, down 0.28% on the day, and is near its 52-week low. The stock shows a bearish technical trend with mixed earnings, including a recent Q1 2026 beat but a Q2 2026 miss. Financially, it has a negative net income margin of -62.14% for 2026, though revenue remains stable at $4.9B. Recent news highlights strategic moves like the Ziggo Group spin-off planned for 2027 and an AI partnership to enhance customer experiences.
The outlook is cautious; while analyst consensus is bullish with a $12.67 price target, high losses and bearish technicals pose risks. Upside potential hinges on successful asset monetization and the Ziggo listing, but investors face volatility from ongoing profitability challenges and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
